Spots Global Cancer Trial Database for stage iv esophageal cancer
Every month we try and update this database with for stage iv esophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | NCT00006245 | Esophageal Canc... | alvocidib paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | NCT00659113 | Esophageal Canc... | cisplatin tegafur-gimerac... cytology specim... endoscopic biop... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer | NCT04670445 | Stage IV Melano... Advanced Lung C... Stage IV Non-Sm... Unresectable No... Unresectable St... Small Cell Lung... Stage IV Merkel... Stage IV Cutane... Stage IV Basal ... Stage IV Breast... Stage IV Colore... Stage IV Gastri... Stage IV Esopha... Stage IV Hepato... Stage IV Renal ... Stage IV Bladde... Stage IV Head a... Stage IV Cervic... Stage IV Endome... Stage IV Mesoth... Immunotherapy Immune Checkpoi... | Educational Vid... Usual Care | 18 Years - | Massachusetts General Hospital | |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | NCT01231399 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri... | fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal... | 19 Years - | City of Hope Medical Center | |
| Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy | NCT01243398 | Adenocarcinoma ... Esophageal Canc... | quality-of-life... | 18 Years - | University of Oxford | |
| Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus | NCT00003487 | Adenocarcinoma ... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | NCT01705340 | Adenocarcinoma ... HER2-positive B... Male Breast Can... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Stage IIIC Brea... Stage IIIC Esop... Stage IIIC Gast... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... | Akt inhibitor M... trastuzumab lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | NCT00978549 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain | docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Irinotecan in Treating Patients With Advanced Cancer of the Stomach | NCT00003137 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00061958 | Adenocarcinoma ... Stage III Esoph... Stage IV Esopha... | arsenic trioxid... | 18 Years - | National Cancer Institute (NCI) | |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| DX-8951f in Treating Patients With Metastatic Stomach Cancer | NCT00017212 | Esophageal Canc... Gastric Cancer | exatecan mesyla... | 18 Years - | Daiichi Sankyo | |
| Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | NCT00861094 | Esophageal Canc... | cisplatin 5-FU oxaliplatin radiation thera... Folinic Acid | 18 Years - | UNICANCER | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | NCT00017056 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | NCT00004235 | Esophageal Canc... Gastric Cancer | docetaxel irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00072332 | Esophageal Canc... Gastric Cancer Unspecified Adu... | cisplatin edotecarin | 18 Years - | National Cancer Institute (NCI) | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors | NCT05856500 | Stage IV Gastri... Stage IIIA Gast... Stage IIIB Gast... Stage III Esoph... Stage IV Esopha... | basic nutrition oral supplement... | 18 Years - 80 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | NCT00238407 | Esophageal Canc... | Docetaxel and C... Radiotherapy | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | NCT00896467 | Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | questionnaire a... psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | NCT00075738 | Esophageal Canc... | cisplatin fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | NCT00985192 | Esophageal Canc... Gastric Cancer | everolimus laboratory biom... | 18 Years - | Translational Oncology Research International | |
| Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | NCT00003192 | Esophageal Canc... Gastric Cancer | aminocamptothec... | 18 Years - | University of Chicago | |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | NCT00093652 | Esophageal Canc... | gefitinib oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer | NCT00711412 | Esophageal Canc... | Induction Thera... Induction Thera... Combination The... Combination The... Combination The... Evaluation for ... | 18 Years - 120 Years | Northwestern University | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00030862 | Esophageal Canc... | cisplatin irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | NCT00002984 | Esophageal Canc... | cisplatin fluorouracil paclitaxel surgical proced... radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | NCT00004127 | Esophageal Canc... Gastric Cancer | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | University of Chicago | |
| Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction | NCT00107341 | Esophageal Canc... | bortezomib carboplatin paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction | NCT00891878 | Adenocarcinoma ... Esophageal Canc... | capecitabine sunitinib malat... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00016900 | Esophageal Canc... | liposomal pacli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
| BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | NCT00017043 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Bristol-Myers Squibb | |
| 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | NCT00077545 | Adenocarcinoma ... Recurrent Esoph... Stage IV Esopha... | triapine cisplatin | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | NCT00601692 | Esophageal Canc... | cisplatin docetaxel irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | NCT00040859 | Esophageal Canc... Gastric Cancer | capecitabine oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | NCT00397384 | Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Carcinoma of th... Gastrointestina... Metastatic Gast... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Pancr... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Pancre... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Unresectable Ex... Unresectable Ga... | cetuximab erlotinib hydro... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery | NCT01612546 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | cyclodextrin-ba... Laboratory biom... Pharmacological... | 18 Years - | City of Hope Medical Center | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | NCT00019435 | Bladder Cancer Breast Cancer Colorectal Canc... Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | NCT00978549 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain | docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00061958 | Adenocarcinoma ... Stage III Esoph... Stage IV Esopha... | arsenic trioxid... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | NCT00005607 | Esophageal Canc... Gastric Cancer | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00732745 | Adenocarcinoma ... Esophageal Canc... | docetaxel oxaliplatin vandetanib placebo | 18 Years - | Case Comprehensive Cancer Center | |
| C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer | NCT02344810 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Gastrointestina... Intestinal Aden... Mixed Adenocarc... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | c-Met inhibitor... placebo oxaliplatin leucovorin calc... fluorouracil pharmacological... laboratory biom... | 18 Years - | Eastern Cooperative Oncology Group | |
| Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | NCT00075738 | Esophageal Canc... | cisplatin fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer | NCT00003748 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus | NCT00003321 | Esophageal Canc... | psychosocial as... quality-of-life... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | NCT00054457 | Esophageal Canc... Gastric Cancer | capecitabine docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | NCT01249443 | HIV Infection Recurrent Anal ... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Recurrent Metas... Recurrent Non-s... Recurrent Ovari... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Anal C... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... | vorinostat diagnostic labo... pharmacological... carboplatin paclitaxel | 18 Years - | AIDS Malignancy Consortium | |
| Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach | NCT00020761 | Esophageal Canc... Gastric Cancer | irinotecan hydr... paclitaxel | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer | NCT00655876 | Esophageal Canc... | cetuximab cisplatin paclitaxel radiation thera... | 18 Years - 74 Years | Radiation Therapy Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
